1. Home
  2. DCTH vs BGH Comparison

DCTH vs BGH Comparison

Compare DCTH & BGH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • DCTH
  • BGH
  • Stock Information
  • Founded
  • DCTH 1988
  • BGH 2012
  • Country
  • DCTH United States
  • BGH United States
  • Employees
  • DCTH N/A
  • BGH N/A
  • Industry
  • DCTH Medical/Dental Instruments
  • BGH Investment Managers
  • Sector
  • DCTH Health Care
  • BGH Finance
  • Exchange
  • DCTH Nasdaq
  • BGH Nasdaq
  • Market Cap
  • DCTH 518.0M
  • BGH 318.8M
  • IPO Year
  • DCTH N/A
  • BGH N/A
  • Fundamental
  • Price
  • DCTH $12.98
  • BGH $15.15
  • Analyst Decision
  • DCTH Strong Buy
  • BGH
  • Analyst Count
  • DCTH 4
  • BGH 0
  • Target Price
  • DCTH $22.75
  • BGH N/A
  • AVG Volume (30 Days)
  • DCTH 494.6K
  • BGH 61.5K
  • Earning Date
  • DCTH 03-06-2025
  • BGH 01-01-0001
  • Dividend Yield
  • DCTH N/A
  • BGH 10.06%
  • EPS Growth
  • DCTH N/A
  • BGH N/A
  • EPS
  • DCTH N/A
  • BGH N/A
  • Revenue
  • DCTH $37,205,000.00
  • BGH N/A
  • Revenue This Year
  • DCTH $112.81
  • BGH N/A
  • Revenue Next Year
  • DCTH $61.78
  • BGH N/A
  • P/E Ratio
  • DCTH N/A
  • BGH N/A
  • Revenue Growth
  • DCTH 1701.69
  • BGH N/A
  • 52 Week Low
  • DCTH $4.26
  • BGH $11.92
  • 52 Week High
  • DCTH $16.97
  • BGH $14.50
  • Technical
  • Relative Strength Index (RSI)
  • DCTH 44.79
  • BGH 36.93
  • Support Level
  • DCTH $12.18
  • BGH $14.97
  • Resistance Level
  • DCTH $14.61
  • BGH $15.35
  • Average True Range (ATR)
  • DCTH 0.77
  • BGH 0.14
  • MACD
  • DCTH -0.00
  • BGH 0.00
  • Stochastic Oscillator
  • DCTH 33.47
  • BGH 45.00

About DCTH Delcath Systems Inc.

Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.

About BGH Barings Global Short Duration High Yield Fund of Beneficial Interests

Barings Global Short Duration High Yield Fund is a diversified, closed-end management investment company. Its investment objective is to seek as high a level of current income as the Adviser determines is consistent with capital preservation.

Share on Social Networks: